|
US4367110A
(en)
|
1979-07-02 |
1983-01-04 |
Toppan Printing Co. |
Decorative laminate and a manufacturing method therefor
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
FR2504010B1
(fr)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
|
|
GB2097032B
(en)
|
1981-04-22 |
1984-09-19 |
Teron International Urban Dev |
A combined ceiling air and services distribution system mechanical chasse and structural roof member
|
|
US4478946A
(en)
|
1981-07-02 |
1984-10-23 |
South African Inventions Development Corporation |
Carrier bound immunosorbent
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
DE3377484D1
(en)
|
1982-04-19 |
1988-09-01 |
Nissan Motor |
Method for controlling reduction ratio of continuously variable transmission with acceleration compensation
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
ATE66469T1
(de)
|
1985-01-14 |
1991-09-15 |
Neorx Corp |
Metall-radionuklid markiertes protein fuer diagnose und therapie.
|
|
US5171582A
(en)
|
1985-07-31 |
1992-12-15 |
Ghent William R |
Treatment of iodine deficiency diseases
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
|
US6106840A
(en)
|
1988-06-23 |
2000-08-22 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US5260422A
(en)
|
1988-06-23 |
1993-11-09 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US4859839A
(en)
|
1988-07-08 |
1989-08-22 |
Counter Computer Corporation |
Point-of-sale terminal for laundry or dry cleaning establishments
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
DE69232875T2
(de)
|
1991-04-23 |
2003-08-21 |
Anergen, Inc. |
MHC-Konjugate zur Verbesserung der Autoimmunität.
|
|
US5200189A
(en)
|
1991-07-23 |
1993-04-06 |
Ecolab Inc. |
Peroxyacid antimicrobial composition
|
|
CA2130997A1
(en)
|
1992-02-27 |
1993-09-02 |
C. Garrison Fathman |
Early antigen for autoimmune diabetes
|
|
JP2631436B2
(ja)
|
1992-07-24 |
1997-07-16 |
徳厚 小島 |
排水立て管継手
|
|
US5972336A
(en)
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
|
AU2076895A
(en)
|
1994-03-28 |
1995-10-17 |
Daiichi Pharmaceutical Co., Ltd. |
Liposomes
|
|
US6103379A
(en)
|
1994-10-06 |
2000-08-15 |
Bar-Ilan University |
Process for the preparation of microspheres and microspheres made thereby
|
|
WO1996018105A1
(en)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Single chain t-cell receptor
|
|
DE19508058A1
(de)
|
1995-02-21 |
1996-08-22 |
Schering Ag |
Verfahren zur Herstellung von DTPA-Tetraestern der terminalen Carbonsäuren und deren Verwendung zur Herstellung pharmazeutischer Mittel
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5840839A
(en)
*
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6033864A
(en)
*
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
DE69730038T2
(de)
|
1996-08-16 |
2004-11-25 |
The President And Fellows Of Harvard College, Cambridge |
Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
|
|
AU741130B2
(en)
|
1997-09-16 |
2001-11-22 |
Oregon Health Sciences University |
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
|
|
BR9908082A
(pt)
|
1998-02-19 |
2000-10-31 |
Harvard College |
Proteìna de fusão do complexo de histocompatibilidade principal classe ii, conjugado dos domìnios de ligação do complexo de histocompatibilidade principal multimérico, processos para detectar células t tendo uma especificidade do complexo definido de mhc / peptìdeo, para conferir a um indivìduo imunidade adotiva a um complexo definido de mhc / peptìdeo, para estimular ou ativar as células t reativas a um complexo definido de mhc / peptìdeo, para seletivamente matar células t reativas a um complexo definido de mhc / peptìdeo, para tolerizar um indivìduo humano a um complexo definido de mhc / peptìdeo, e, ácido nucleico isolado
|
|
EP1094828A4
(en)
|
1998-05-07 |
2005-01-26 |
Univ California |
USE OF TARGETED, NEGLIGATED TISSUE ANTIGENS TO MODULATE IMMUNE REACTIONS
|
|
DE19825371A1
(de)
|
1998-06-06 |
1999-12-09 |
Bayer Ag |
Elektrochrome Anzeigevorrichtung mit isolierten Zuleitungen
|
|
IL125608A0
(en)
|
1998-07-30 |
1999-03-12 |
Yeda Res & Dev |
Tumor associated antigen peptides and use of same as anti-tumor vaccines
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
US6150022A
(en)
|
1998-12-07 |
2000-11-21 |
Flex Products, Inc. |
Bright metal flake based pigments
|
|
JP2000213425A
(ja)
|
1999-01-20 |
2000-08-02 |
Hino Motors Ltd |
Ｅｇｒク―ラ
|
|
US7090973B1
(en)
*
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
HUP0201222A3
(en)
|
1999-05-06 |
2004-07-28 |
Genetics Inst Llc Delaware All |
Use of soluble constimulatory molecules to enhance immune responses
|
|
CA2386377A1
(en)
|
1999-10-06 |
2001-04-12 |
The Trustees Of The University Of Pennsylvania |
Cell targeting compositions and methods of using the same
|
|
US6585947B1
(en)
|
1999-10-22 |
2003-07-01 |
The Board Of Trustess Of The University Of Illinois |
Method for producing silicon nanoparticles
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
KR100379250B1
(ko)
|
2000-12-04 |
2003-04-08 |
한국과학기술연구원 |
나노 단위 크기의 금속 입자가 함유된 고분자 복합 소재및 그 제조 방법
|
|
US7094555B2
(en)
|
2001-04-05 |
2006-08-22 |
Benaroya Research Institute At Virginia Mason |
Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
|
|
DE10117858A1
(de)
|
2001-04-10 |
2002-10-24 |
Gsf Forschungszentrum Umwelt |
MHC-Tetramere
|
|
US20070129307A1
(en)
|
2001-06-22 |
2007-06-07 |
The University Of British Columbia |
Insulin epitopes for the treatment of type 1 diabetes
|
|
EP1399740A2
(en)
|
2001-06-22 |
2004-03-24 |
The University of British Columbia |
Type 1 diabetes diagnostics and therapeutics
|
|
US20030124149A1
(en)
|
2001-07-06 |
2003-07-03 |
Shalaby Shalaby W. |
Bioactive absorbable microparticles as therapeutic vaccines
|
|
EP1990040A1
(en)
|
2001-07-10 |
2008-11-12 |
North Carolina State University |
Nanoparticle delivery vehicle
|
|
DE10144252A1
(de)
|
2001-08-31 |
2003-03-27 |
Fraunhofer Ges Forschung |
Nanopartikel mit daran immobilisiertem biologisch aktivem TNF
|
|
DK1581119T3
(da)
*
|
2001-12-17 |
2013-05-13 |
Corixa Corp |
Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
|
|
US6688494B2
(en)
|
2001-12-20 |
2004-02-10 |
Cima Nanotech, Inc. |
Process for the manufacture of metal nanoparticle
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
US20040115216A1
(en)
|
2002-07-12 |
2004-06-17 |
The Johns Hopkins University |
Reagents and methods for engaging unique clonotypic lymphocyte receptors
|
|
DE10310261A1
(de)
|
2003-03-05 |
2004-09-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Identifizierung von Antigen-Epitopen
|
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
|
US6929675B1
(en)
|
2003-04-24 |
2005-08-16 |
Sandia Corporation |
Synthesis metal nanoparticle
|
|
US20050118102A1
(en)
|
2003-04-28 |
2005-06-02 |
Intematix Corporation |
Spin resonance heating and/or imaging in medical applications
|
|
DK1623017T3
(da)
|
2003-05-08 |
2011-01-10 |
Life Technologies Corp |
Frembringelse og isolering af antigenspecifikke T-celler
|
|
US8758767B2
(en)
|
2003-05-20 |
2014-06-24 |
Albert Einstein College Of Medicine Of Yeshiva University |
Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof
|
|
US7060121B2
(en)
|
2003-06-25 |
2006-06-13 |
Hsing Kuang Lin |
Method of producing gold nanoparticle
|
|
WO2005007673A2
(en)
|
2003-07-03 |
2005-01-27 |
Rush University Medical Center |
Immunogenic peptides
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
GB0321937D0
(en)
|
2003-09-19 |
2003-10-22 |
Univ Liverpool |
Nanoparticle conjugates and method of production thereof
|
|
CA2540633C
(en)
|
2003-10-09 |
2012-12-04 |
Emerson Electric Co. |
Valve assembly
|
|
DE102004023187A1
(de)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
GB0417954D0
(en)
|
2004-08-12 |
2004-09-15 |
Avidex Ltd |
Cellulat TCR ligand assay method
|
|
JP5117191B2
(ja)
|
2004-10-01 |
2013-01-09 |
ミダテック リミテッド |
抗原及びアジュバントを含むナノ粒子、並びに免疫原性構造
|
|
WO2006054806A1
(ja)
|
2004-11-22 |
2006-05-26 |
Locomogene, Inc. |
クローン病関連自己抗原
|
|
US7462446B2
(en)
|
2005-03-18 |
2008-12-09 |
University Of Washington |
Magnetic nanoparticle compositions and methods
|
|
US20070059775A1
(en)
|
2005-03-29 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques
|
|
US7562421B2
(en)
|
2005-04-03 |
2009-07-21 |
Magen Eco Energy A.C.S. Ltd. |
Connecting clasp
|
|
US7326399B2
(en)
|
2005-04-15 |
2008-02-05 |
Headwaters Technology Innovation, Llc |
Titanium dioxide nanoparticles and nanoparticle suspensions and methods of making the same
|
|
US20060246524A1
(en)
|
2005-04-28 |
2006-11-02 |
Christina Bauer |
Nanoparticle conjugates
|
|
JPWO2007024026A1
(ja)
|
2005-08-25 |
2009-03-05 |
明石 満 |
Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
|
CA2631714C
(en)
|
2005-12-02 |
2014-09-16 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
|
WO2007084775A2
(en)
|
2006-01-20 |
2007-07-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for modulation of suppressor t cell activation
|
|
PT2476435T
(pt)
|
2006-08-11 |
2018-03-05 |
Life Sciences Res Partners Vzw |
Péptidos imunogénicos e a sua utilização em distúrbios imunitários
|
|
US7816814B1
(en)
|
2006-08-18 |
2010-10-19 |
Hennessy Michael J |
Bi-directional power converters
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
JP2010530955A
(ja)
|
2006-12-29 |
2010-09-16 |
ユニヴァーシティ オブ ワシントン |
二重機能性非汚染表面および材料
|
|
US8889117B2
(en)
|
2007-02-15 |
2014-11-18 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
|
US20140105980A1
(en)
|
2012-10-11 |
2014-04-17 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
DK2131856T3
(da)
|
2007-03-07 |
2014-12-15 |
Uti Limited Partnership |
Sammensætninger og fremgangsmåder til forebyggelsen og behandlingen af autoimmune tilstande
|
|
US20150250871A1
(en)
|
2007-03-07 |
2015-09-10 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
US20100151031A1
(en)
|
2007-03-23 |
2010-06-17 |
Desimone Joseph M |
Discrete size and shape specific organic nanoparticles designed to elicit an immune response
|
|
EP2167537A2
(en)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Compiled methods for analysing and sorting samples
|
|
WO2009013741A2
(en)
|
2007-07-22 |
2009-01-29 |
Camtek Ltd |
Method and system for controlling a manufacturing process
|
|
JP5085240B2
(ja)
|
2007-09-03 |
2012-11-28 |
日本電波工業株式会社 |
水晶デバイス及び水晶デバイスの製造方法
|
|
US9295736B2
(en)
|
2007-09-24 |
2016-03-29 |
Bar Ilan University |
Polymer nanoparticles coated by magnetic metal oxide and uses thereof
|
|
WO2009064273A1
(en)
|
2007-11-16 |
2009-05-22 |
Paul Appelbaum |
Apparatus and method for packaging articles in clear plastic packages
|
|
EP2231181B1
(en)
*
|
2007-12-17 |
2016-02-17 |
Marfl AB |
New vaccine for the treatment of mycobacterium related disorders
|
|
US8629098B2
(en)
|
2008-01-15 |
2014-01-14 |
Yale University |
Compositions and methods for adoptive and active immunotherapy
|
|
EP2240782A2
(en)
|
2008-02-04 |
2010-10-20 |
Ulive Enterprises Limited |
Nanoparticle conjugates
|
|
EP2262480B1
(en)
|
2008-03-04 |
2018-02-14 |
Liquidia Technologies, Inc. |
Immunomodulator particles
|
|
WO2009126835A2
(en)
|
2008-04-09 |
2009-10-15 |
University Of Washington Techtransfer Invention Licensing |
Magnetic nanoparticle and method for imaging t cells
|
|
US20090258355A1
(en)
|
2008-04-11 |
2009-10-15 |
Brookhaven Science Associates, Llc |
Nanoscale Clusters and Methods of Making Same
|
|
CA2735006A1
(en)
|
2008-08-25 |
2010-03-11 |
Amplimmune, Inc. |
Pd-1 antagonists and methods of use thereof
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
CA2642141A1
(en)
|
2008-10-20 |
2010-04-20 |
Innovative Microelectronics Inc. |
Flange alignment pin
|
|
CA2743590A1
(en)
|
2008-11-12 |
2010-05-20 |
Yeda Research And Development Co. Ltd. |
Diagnosis of multiple sclerosis
|
|
WO2010080032A2
(en)
|
2009-01-09 |
2010-07-15 |
Stichting Het Nederlands Kanker Instituut |
Bead-assisted viral transduction
|
|
CA2750098A1
(en)
|
2009-01-20 |
2010-07-29 |
Myelin Repair Foundation, Inc. |
Compositions and methods for induction of antigen-specific tolerance
|
|
US8383085B2
(en)
|
2009-05-29 |
2013-02-26 |
University Of Manitoba |
Methods of making iron-containing nanoparticles
|
|
US10464987B2
(en)
|
2009-10-06 |
2019-11-05 |
Abbvie Inc. |
Human single-chain T cell receptors
|
|
GB0922066D0
(en)
|
2009-12-17 |
2010-02-03 |
Univ Belfast |
Modulator
|
|
GB201003088D0
(en)
|
2010-02-24 |
2010-04-14 |
Univ Exeter |
Method for the preparation of a novel nanoparticle conjugate
|
|
ES2645509T3
(es)
|
2010-07-26 |
2017-12-05 |
Qu Biologics Inc |
Composiciones antiinflamatorias inmunogénicas
|
|
JP6108112B2
(ja)
|
2010-08-25 |
2017-04-05 |
ラオ ダヴルリ，ラマモハン |
改良されたルフィナミド調製プロセス
|
|
KR20130107293A
(ko)
|
2010-09-03 |
2013-10-01 |
오레곤 헬스 앤드 사이언스 유니버시티 |
공유 결합된 펩티드를 갖는 재조합 ｔ 세포 수용체 리간드
|
|
CA2813064C
(en)
|
2010-09-29 |
2021-06-01 |
Uti Limited Partnership |
Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
KR101468769B1
(ko)
|
2011-03-04 |
2014-12-08 |
사회복지법인 삼성생명공익재단 |
갑상선암 특이적 자성나노입자 복합체 및 이의 용도
|
|
WO2013034726A1
(en)
|
2011-09-07 |
2013-03-14 |
Midatech Limited |
Nanoparticle-peptide compositions
|
|
EP2758780A4
(en)
|
2011-09-22 |
2015-09-16 |
Marv Entpr Llc |
METHOD OF TREATING MULTIPLE SCLEROSIS
|
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
|
US20130128138A1
(en)
|
2011-11-18 |
2013-05-23 |
Shenzhen China Star Optoelectronics Technolog Co., LTD. |
Flat Panel Display Device, Stereoscopic Display Device, Plasma Display Device
|
|
JP2015500296A
(ja)
|
2011-12-09 |
2015-01-05 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
定義された動的形状を有する人工抗原提示細胞
|
|
US8809057B2
(en)
|
2012-01-04 |
2014-08-19 |
Raytheon Bbn Technologies Corp. |
Methods of evaluating gene expression levels
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
US20150150996A1
(en)
|
2012-06-06 |
2015-06-04 |
Northwestern University |
Compositions and methods for antigen-specific tolerance
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
RU2015129640A
(ru)
|
2012-12-21 |
2017-01-26 |
Ф.Хоффманн-Ля Рош Аг |
Связанные дисульфидом мультивалентные многофункциональные белки, содержащие молекулы гкгс класса 1
|
|
KR102266819B1
(ko)
|
2013-04-29 |
2021-06-18 |
에프. 호프만-라 로슈 아게 |
Fc-수용체 결합 개질된 비대칭 항체 및 이의 사용 방법
|
|
SG11201509637VA
(en)
|
2013-08-31 |
2015-12-30 |
Halliburton Energy Services Inc |
Deflector assembly for a lateral wellbore
|
|
US9335768B2
(en)
|
2013-09-12 |
2016-05-10 |
Lam Research Corporation |
Cluster mass flow devices and multi-line mass flow devices incorporating the same
|
|
SG10201912301XA
(en)
|
2013-11-04 |
2020-02-27 |
Uti Lp |
Methods and compositions for sustained immunotherapy
|
|
AU2015279738A1
(en)
|
2014-06-25 |
2016-12-22 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
JP6891112B2
(ja)
|
2014-11-20 |
2021-06-18 |
プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ |
免疫チェックポイントの調節因子を評価するためのシステム及び方法
|
|
IL286025B2
(en)
|
2014-12-24 |
2023-11-01 |
Neximmune Inc |
Nanoparticle preparations and immunotherapy methods
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
WO2016145605A1
(zh)
|
2015-03-17 |
2016-09-22 |
王忠堂 |
一种便携式智能超声多普勒动态实时监测装置
|
|
US12011480B2
(en)
|
2015-05-06 |
2024-06-18 |
Uti Limited Partnership |
Nanoparticle compositions for sustained therapy
|
|
US10858760B2
(en)
|
2015-06-01 |
2020-12-08 |
Medigene Immunotherapies Gmbh |
T cell receptor library
|
|
EP3538559B1
(en)
|
2016-11-09 |
2025-04-09 |
UTI Limited Partnership |
Recombinant pmhc class ii molecules
|
|
RU2019135533A
(ru)
|
2017-04-07 |
2021-05-07 |
Ютиай Лимитед Партнершип |
Анализ измерения эффективности рецепторно-лигандных взаимодействий в лекарственных нанолекарственных средствах
|
|
CN111741746A
(zh)
|
2017-11-29 |
2020-10-02 |
乌第有限合伙公司 |
治疗自身免疫性疾病的方法
|